<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="drug, especially in primary hospitals. During the ongoing outbreak of" exact="coronavirus disease 2019" post="(COVID-19), most patients with COVID-19 who are symptomatic have"/>
 <result pre="oseltamivir is effective in treating SARS-CoV. With the epidemic of" exact="coronavirus disease 2019" post="(COVID-19) caused by SARS-CoV-2, oseltamivir has once again become"/>
 <result pre="and key enzymes of SARS-CoV-2 are important targets for inhibiting" exact="SARS-CoV-2 infection" post="[6], [7], [8], [9], [10]. Since the SARS outbreak"/>
 <result pre="2.6.1 Study design We retrospectively analyzed 627 patients diagnosed with" exact="SARS-CoV-2 infection" post="at the Second Hospital of Wuhan, Wuhan Union Hospital,"/>
 <result pre="China. The enrollment criteria were: 1. patients were diagnosed with" exact="SARS-CoV-2 infection" post="and negative for influenza A and B nucleic acid"/>
 <result pre="2 Structural alignment analyzed by TM-align program. Protein TM-score Final" exact="Influenza" post="B neuraminidase 0.94460 In about the same fold S"/>
</results>
